info@endoid.com

What is Endometriosis?

Endometriosis is a chronic, inflammatory, systemic disease with long-term negative impact on various aspects of the quality of life in affected women¹. It can start at the onset of menstruation and last until menopause. Some of the classical symptoms include:

Abdominal bloating, nausea and fatigue

Debilitating pain during menstrual periods

Pain during bowel movements and/or urination

Pain during sexual intercourse

Unexplained Infertility

Depression and anxiety

7-12

Years to diagnosis

Women affected globally

190M

First

Non-invasive test

Breaking the Silence

Endometriosis affects roughly 10% (190 million) of reproductive age woman and girls globally². Access to early diagnosis and effective treatment is important, but numerous barriers such as the presentation of symptoms that can be attributed to many illnesses and a lack of understanding from both patients and practitioners add to that delay. As a result, this debilitating disease remains misdiagnosed, misunderstood and ineffectively treated³.

What is EndoID?

EndoIDTM is an ELISA based test that can be used to detect and measure the concentration of two biomarkers, SNGC and BCL-6, both found to be prevalent in the blood serum of woman suffering from endometriosis and unexplained infertility. Our clinical research supports that elevated levels of Synuclein Gamma (SNCG) — a protein involved in cellular growth and division, along with B-cell lymphoma-6 (BCL-6), a protein that regulates the transcription of genetic information, are considered promising biomarkers.


While EndoIDTM might not provide a definitive diagnosis, it is the first step towards a non-invasive screening test and early intervention. In the absence of a diagnosis, the clinical use of EndoIDTM should moderate the progression of the disease and provide insight for those dealing with unexplained infertility. Our goal is to alleviate your pain sooner by opening the doors to treatment options and giving relief to those who are suffering needlessly.


Innovative Endometriosis Detection & Treatment

EndoIDTM tests for two key biomarkers Synuclein Gamma (SNCG) and BCL-6 in your blood. Elevated levels of these proteins strongly indicate the presence of endometriosis, enabling early, non-invasive detection4.

Contact Us

Get Tested

Getting tested for endometriosis and unexplained infertility has never been easier. Previously, a diagnosis required invasive laparoscopy, but with EndoIDTM, a simple blood test performed during a routine visit to your reproductive specialist or Ob-Gyn can provide critical insights.

Visit a participating reproductive specialist or Ob-Gyn offering EndoIDTM testing.

Confirm the availability of EndoIDTM collection kits at your clinic in advance

For those not currently undergoing IVF, order an EndoIdTM Collection Kit online. The kit ships directly to your home with clear instructions for blood collection at your physician’s office or nearest LifeLabs.

Results will be sent to your doctor to guide your treatment options, helping you get the answers and care you deserve.

How It Works?

Order EndoIDTM Collection Kit online or visit a participating center

Visit your doctor or LifeLabs for a simple blood draw

Biomarker analysis performed at certified labs

Results shared with your physician

Personalized treatment planning and early intervention

Treatment Options for Endometriosis

No known cure, but effective management is possible (5).

Pain Relief Medications

Target symptom relief and improve quality of life.

Surgical Interventions

Laparoscopic removal of lesions can alleviate symptoms but carries risks of recurrence and possible reoperation.

Hormone Therapy

Helps manage symptoms but usually suppresses ovulation, not suitable for women trying to conceive.

End Your Pain and Suffering Today.
Contact Us:

1. Macer ML & Taylor HS. Obstet Gynecol Clin North Am_. 2012 Dec;39(4):535-49.

2. Zondervan KT, Bekcer CM & Missmer SA. N Engl J Med 2020;382:1244-1256

3. Horne AW, Missmer SA. bmj. 2022 Nov 14;379.

4. Srivastava A et al. Eur Journal of OBGYN & Reproductive Biol. Oct 2025 https://doi.org/10.1016/j.ejogrb.2025.114778

5. Di Spiezio Sardo et al. Curr Opin Obstet Gynecol. 2025 Jun 1;37(3):149-157.

Location

623 Fortune Cres #100

Kingston ON K7P 0L5, Canada

The EndoIDTM test is not intended to substitute for an assessment by a medical professional. Patient management decisions are based on the independent medical judgment of the physician, and the ELISA test results should be considered in conjunction with all relevant imaging, clinical findings, patient and family history, as well as patient preference. It is for screening purposes only and should not be viewed or relied upon as any form of assurance or guarantee. A negative result does not definitively rule out the presence of endometriosis and/or unexplained infertility and should be evaluated in the context of the patient's symptoms and additional testing. Samples will be used for the test(s) requested by your doctor and by our internal research team as part of our continuous quality improvement mandate. The EndoIDTM test is approved by the Central Drugs Standard Control Organization (CDSCO) of India as a Class B medical device and is currently available in India only.

© 2025 by EndoIDTM SYNG Pharmaceuticals

The EndoIDTM test is not intended to substitute for an assessment by a medical professional. Patient management decisions are based on the independent medical judgment of the physician, and the ELISA test results should be considered in conjunction with all relevant imaging, clinical findings, patient and family history, as well as patient preference. It is for screening purposes only and should not be viewed or relied upon as any form of assurance or guarantee. A negative result does not definitively rule out the presence of endometriosis and/or unexplained infertility and should be evaluated in the context of the patient's symptoms and additional testing. Samples will be used for the test(s) requested by your doctor and by our internal research team as part of our continuous quality improvement mandate. The EndoIDTM test is approved by the Central Drugs Standard Control Organization (CDSCO) of India as a Class B medical device and is currently available in India only.

© 2025 by EndoIDTM SYNG Pharmaceuticals

What is

?

EndoIDTM is an ELISA based test that can be used to detect and measure the concentration of two biomarkers, SNGC and BCL-6, both found to be prevalent in the blood serum of woman suffering from endometriosis and unexplained infertility. Our clinical research supports that elevated levels of Synuclein Gamma (SNCG) — a protein involved in cellular growth and division, along with B-cell lymphoma-6 (BCL-6), a protein that regulates the transcription of genetic information, are considered promising biomarkers.


While EndoIDTM might not provide a definitive diagnosis, it is the first step towards a non-invasive screening test and early intervention. In the absence of a diagnosis, the clinical use of EndoIDTM should moderate the progression of the disease and provide insight for those dealing with unexplained infertility. Our goal is to alleviate your pain sooner by opening the doors to treatment options and giving relief to those who are suffering needlessly.

Innovative Endometriosis Detection & Treatment

EndoIDTM tests for two key biomarkers Synuclein Gamma (SNCG) and BCL-6 in your blood. Elevated levels of these proteins strongly indicate the presence of endometriosis, enabling early, non-invasive detection.

Contact Us

EndoIDTM empowers early intervention—transforming care for endometriosis and unexplained infertility.

How it Works?

Order EndoIDTM Collection Kit online or visit a participating center

Visit your doctor or LifeLabs for a simple blood draw

Biomarker analysis performed at certified labs

Results shared with your physician

Personalized treatment planning and early intervention

Treatment Options for Endometriosis

No known cure, but effective management is possible.

Pain Relief Medications

Target symptom relief and improve quality of life.

Surgical Interventions

Laparoscopic removal of lesions can alleviate symptoms but carries risks of recurrence and possible reoperation.

Hormone Therapy

Helps manage symptoms but usually suppresses ovulation, not suitable for women trying to conceive.

End Your Pain and Suffering Today. Contact Us:

Endometriosis &

Unexplained Infertility

Endometriosis is a chronic, inflammatory, systemic disease with long-term negative impact on various aspects of the Quality of Life in affected women. It can start at the onset of menstruation and last until menopause. Some of the classical symptoms include:

Debilitating pain during menstrual periods

Pain during bowel movements and/or urination

Abdominal bloating, nausea and fatigue

Chronic pelvic pain, depression and anxiety

Pain during sexual intercourse

Infertility

Breaking the Silence on Endometriosis

Endometriosis affects roughly 10% (190 million) of reproductive age woman and girls globally. Access to early diagnosis and effective treatment is important, but numerous barriers such as the presentation of symptoms that can be attributed to many illnesses and a lack of understanding from both patients and practitioners add to that delay. As a result, this debilitating disease remains misdiagnosed, misunderstood and ineffectively treated.

7-12

Years to diagnosis

Women affected globally

190M

Non-invasive test

First

Get Tested

Getting tested for endometriosis and unexplained infertility has never been easier. Previously, diagnosis required invasive laparoscopy, but with EndoIDTM, a simple blood test performed during a routine visit to your reproductive specialist or Ob-Gyn can provide critical insights.

Visit a participating reproductive specialist or Ob-Gyn offering EndoIDTM testing.

Confirm the availability of EndoIDTM collection kits at your clinic in advance

For those not currently undergoing IVF, order an EndoIDTM Collection Kit online. The kit ships directly to your home with clear instructions for blood collection at your physician’s office or nearest LifeLabs.

Results will be sent to your doctor to guide your treatment options, helping you get the answers and care you deserve.

Get Tested

Getting tested for endometriosis and unexplained infertility has never been easier. Previously, diagnosis required invasive laparoscopy, but with EndoIDTM, a simple blood test performed during a routine visit to your reproductive specialist or Ob-Gyn can provide critical insights.

Visit a participating reproductive specialist or Ob-Gyn offering EndoIDTM testing.

Confirm the availability of EndoIDTM collection kits at your clinic in advance

For those not currently undergoing IVF, order an EndoIDTM Collection Kit online. The kit ships directly to your home with clear instructions for blood collection at your physician’s office or nearest LifeLabs.

Results will be sent to your doctor to guide your treatment options, helping you get the answers and care you deserve.

References

1. Macer ML & Taylor HS. Obstet Gynecol Clin North Am_. 2012 Dec;39(4):535-49.

2. Zondervan KT, Bekcer CM & Missmer SA. N Engl J Med 2020;382:1244-1256

3. Horne AW, Missmer SA. bmj. 2022 Nov 14;379.

4. Di Spiezio Sardo et al. Curr Opin Obstet Gynecol. 2025 Jun 1;37(3):149-157.

Endometriosis & Unexplained Infertility

Endometriosis is a chronic, inflammatory, systemic disease with long-term negative impact on various aspects of the Quality of Life in affected women. It can start at the onset of menstruation and last until menopause. Some of the classical symptoms include:

Debilitating pain during menstrual periods

Pain during sexual intercourse

Chronic pelvic pain, depression and anxiety

Pain during bowel movements and/or urination

Abdominal bloating, nausea and fatigue

Infertility

Breaking the Silence on Endometriosis

Endometriosis affects roughly 10% (190 million) of reproductive age woman and girls globally. Access to early diagnosis and effective treatment is important, but numerous barriers such as the presentation of symptoms that can be attributed to many illnesses and a lack of understanding from both patients and practitioners add to that delay. As a result, this debilitating disease remains misdiagnosed, misunderstood and ineffectively treated.

7-12

Years to diagnosis

Women affected globally

190M

Non-invasive test

First

What is

?

EndoIDTM is an ELISA based test that can be used to detect and measure the concentration of two biomarkers, SNGC and BCL-6, both found to be prevalent in the blood serum of woman suffering from endometriosis and unexplained infertility. Our clinical research supports that elevated levels of Synuclein Gamma (SNCG) — a protein involved in cellular growth and division, along with B-cell lymphoma-6 (BCL-6), a protein that regulates the transcription of genetic information, are considered promising biomarkers.


While EndoIDTM might not provide a definitive diagnosis, it is the first step towards a non-invasive screening test and early intervention. In the absence of a diagnosis, the clinical use of EndoIDTM should moderate the progression of the disease and provide insight for those dealing with unexplained infertility. Our goal is to alleviate your pain sooner by opening the doors to treatment options and giving relief to those who are suffering needlessly.

Innovative Endometriosis Detection & Treatment

EndoIDTM tests for two key biomarkers Synuclein Gamma (SNCG) and BCL-6 in your blood. Elevated levels of these proteins strongly indicate the presence of endometriosis, enabling early, non-invasive detection.

Contact Us

EndoIDTM empowers early intervention—transforming care for endometriosis and unexplained infertility.

Get Tested

Getting tested for endometriosis and unexplained infertility has never been easier. Previously, diagnosis required invasive laparoscopy, but with EndoIDTM, a simple blood test performed during a routine visit to your reproductive specialist or Ob-Gyn can provide critical insights.

Visit a participating reproductive specialist or Ob-Gyn offering EndoIDTM testing.

Confirm the availability of EndoIDTM collection kits at your clinic in advance

For those not currently undergoing IVF, order an EndoIDTM Collection Kit online. The kit ships directly to your home with clear instructions for blood collection at your physician’s office or nearest LifeLabs.

Results will be sent to your doctor to guide your treatment options, helping you get the answers and care you deserve.

Treatment Options for Endometriosis

No known cure, but effective management is possible.

Pain Relief Medications

Target symptom relief and improve quality of life.

Surgical Interventions

Laparoscopic removal of lesions can alleviate symptoms but carries risks of recurrence and possible reoperation.

Hormone Therapy

Helps manage symptoms but usually suppresses ovulation, not suitable for women trying to conceive.

End Your Pain and Suffering Today. Contact Us:

How it Works?

Order EndoIDTM Collection Kit online or visit a participating center

Biomarker analysis performed at certified labs

Personalized treatment planning and early intervention

Visit your doctor or LifeLabs for a simple blood draw

Results shared with your physician

References

1. Macer ML & Taylor HS. Obstet Gynecol Clin North Am_. 2012 Dec;39(4):535-49.

2. Zondervan KT, Bekcer CM & Missmer SA. N Engl J Med 2020;382:1244-1256

3. Horne AW, Missmer SA. bmj. 2022 Nov 14;379.

4. Di Spiezio Sardo et al. Curr Opin Obstet Gynecol. 2025 Jun 1;37(3):149-157.

EndoIDTM is an ELISA based test that can be used to detect and measure the concentration of two biomarkers, SNGC and BCL-6, both found to be prevalent in the blood serum of woman suffering from endometriosis and unexplained infertility. Our clinical research supports that elevated levels of Synuclein Gamma (SNCG) — a protein involved in cellular growth and division, along with B-cell lymphoma-6 (BCL-6), a protein that regulates the transcription of genetic information, are considered promising biomarkers.


While EndoIDTM might not provide a definitive diagnosis, it is the first step towards a non-invasive screening test and early intervention. In the absence of a diagnosis, the clinical use of EndoIDTM should moderate the progression of the disease and provide insight for those dealing with unexplained infertility. Our goal is to alleviate your pain sooner by opening the doors to treatment options and giving relief to those who are suffering needlessly.

What is

?

Innovative Endometriosis Detection & Treatment

EndoIDTM tests for two key biomarkers Synuclein Gamma (SNCG) and BCL-6 in your blood. Elevated levels of these proteins strongly indicate the presence of endometriosis, enabling early, non-invasive detection.

Contact Us

EndoIDTM empowers early intervention—transforming care for endometriosis and unexplained infertility.

How it Works?

Order EndoIDTM Collection Kit online or visit a participating center

Visit your doctor or LifeLabs for a simple blood draw

Biomarker analysis performed at certified labs

Results shared with your physician

Personalized treatment planning and early intervention

Treatment Options for Endometriosis

No known cure, but effective management is possible⁴.

Pain Relief Medications

Target symptom relief and improve quality of life.

Surgical Interventions

Laparoscopic removal of lesions can alleviate symptoms but carries risks of recurrence and possible reoperation.

Hormone Therapy

Helps manage symptoms but usually suppresses ovulation, not suitable for women trying to conceive.

End Your Pain and Suffering Today.
Contact Us:

Endometriosis &

Unexplained Infertility

Endometriosis is a chronic, inflammatory, systemic disease with long-term negative impact on various aspects of the Quality of Life in affected women¹. It can start at the onset of menstruation and last until menopause. Some of the classical symptoms include:

Debilitating pain during menstrual periods

Pain during bowel movements and/or urination

Chronic pelvic pain, depression and anxiety

Abdominal bloating, nausea and fatigue

Infertility

Pain during sexual intercourse

Breaking the Silence on Endometriosis

Endometriosis affects roughly 10% (190 million) of reproductive age woman and girls globally². Access to early diagnosis and effective treatment is important, but numerous barriers such as the presentation of symptoms that can be attributed to many illnesses and a lack of understanding from both patients and practitioners add to that delay. As a result, this debilitating disease remains misdiagnosed, misunderstood and ineffectively treated³.

7-12

Years to diagnosis

Women affected globally

190M

First

Non-invasive test

Get Tested

Getting tested for endometriosis and unexplained infertility has never been easier. Previously, diagnosis required invasive laparoscopy, but with EndoIDTM, a simple blood test performed during a routine visit to your reproductive specialist or Ob-Gyn can provide critical insights.

Visit a participating reproductive specialist or Ob-Gyn offering EndoIDTM testing.

Confirm the availability of EndoIDTM collection kits at your clinic in advance

For those not currently undergoing IVF, order an EndoIDTM Collection Kit online. The kit ships directly to your home with clear instructions for blood collection at your physician’s office or nearest LifeLabs.

Results will be sent to your doctor to guide your treatment options, helping you get the answers and care you deserve.

Get Tested

Getting tested for endometriosis and unexplained infertility has never been easier. Previously, diagnosis required invasive laparoscopy, but with EndoIDTM, a simple blood test performed during a routine visit to your reproductive specialist or Ob-Gyn can provide critical insights.

Visit a participating reproductive specialist or Ob-Gyn offering EndoIDTM testing.

Confirm the availability of EndoIDTM collection kits at your clinic in advance

For those not currently undergoing IVF, order an EndoIDTM Collection Kit online. The kit ships directly to your home with clear instructions for blood collection at your physician’s office or nearest LifeLabs.

Results will be sent to your doctor to guide your treatment options, helping you get the answers and care you deserve.

1. Macer ML & Taylor HS. Obstet Gynecol Clin North Am_. 2012 Dec;39(4):535-49.

2. Zondervan KT, Bekcer CM & Missmer SA. N Engl J Med 2020;382:1244-1256

3. Horne AW, Missmer SA. bmj. 2022 Nov 14;379.

4. Di Spiezio Sardo et al. Curr Opin Obstet Gynecol. 2025 Jun 1;37(3):149-157.

Location

623 Fortune Cres #100

Kingston ON K7P 0L5, Canada

The EndoIDTM test is not intended to substitute for an assessment by a medical professional. Patient management decisions are based on the independent medical judgment of the physician, and the ELISA test results should be considered in conjunction with all relevant imaging, clinical findings, patient and family history, as well as patient preference. It is for screening purposes only and should not be viewed or relied upon as any form of assurance or guarantee. A negative result does not definitively rule out the presence of endometriosis and/or unexplained infertility and should be evaluated in the context of the patient's symptoms and additional testing. Samples will be used for the test(s) requested by your doctor and by our internal research team as part of our continuous quality improvement mandate. The EndoIDTM test is approved by the Central Drugs Standard Control Organization (CDSCO) of India as a Class B medical device and is currently available in India only.

The EndoIDTM test is not intended to substitute for an assessment by a medical professional. Patient management decisions are based on the independent medical judgment of the physician, and the ELISA test results should be considered in conjunction with all relevant imaging, clinical findings, patient and family history, as well as patient preference. It is for screening purposes only and should not be viewed or relied upon as any form of assurance or guarantee. A negative result does not definitively rule out the presence of endometriosis and/or unexplained infertility and should be evaluated in the context of the patient's symptoms and additional testing. Samples will be used for the test(s) requested by your doctor and by our internal research team as part of our continuous quality improvement mandate. The EndoIDTM test is approved by the Central Drugs Standard Control Organization (CDSCO) of India as a Class B medical device and is currently available in India only.

© 2025 by EndoIDTM SYNG Pharmaceuticals

info@endoid.com